Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(1), P. 110 - 110
Published: Jan. 19, 2025
Reactive
oxygen
and
nitrogen
species
(ROS;
RNS)
are
natural
bioproducts
of
cellular
metabolism,
particularly
produced
within
the
mitochondria
during
energy
production
[...]
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 6, 2025
Abstract
Neurodegenerative
diseases,
particularly
Alzheimer's
disease
and
Parkinson's
disease,
present
formidable
challenges
in
modern
medicine
due
to
their
complex
pathologies
the
absence
of
curative
treatments.
Despite
advances
symptomatic
management,
early
diagnosis
remains
essential
for
mitigating
progression
improving
patient
outcomes.
Traditional
diagnostic
methods,
such
as
MRI,
PET,
cerebrospinal
fluid
biomarker
analysis,
are
often
inadequate
detection
these
diseases.
Emerging
porous
materials,
including
metal–organic
frameworks
(MOFs),
covalent–organic
(COFs),
MXene,
zeolites,
silicon,
offer
promising
new
approaches
neurodegenerative
These
characterized
by
highly
tunable
physicochemical
properties,
have
potential
capture
concentrate
disease‐specific
biomarkers
amyloid‐beta
(Aβ),
tau
protein,
alpha‐synuclein
(α‐Syn).
The
integration
materials
into
advanced
biosensors
real‐time
holds
promise
revolutionizing
neurodiagnostic,
enabling
non‐invasive,
sensitive,
specific
platforms.
Furthermore,
incorporation
artificial
intelligence
(AI)
machine
learning
(ML)
techniques
analysis
sensor
data
enhances
accuracy
allows
more
efficient
interpretation
profiles.
AI
ML
can
optimize
feature
selection,
improve
pattern
recognition,
facilitate
prediction
progression,
making
them
indispensable
tools
personalized
medicine.
This
review
explores
diagnostics,
emphasizing
design,
functionality,
synergistic
role
advancing
clinical
applications.
Journal of Cellular and Molecular Medicine,
Journal Year:
2025,
Volume and Issue:
29(2)
Published: Jan. 1, 2025
ABSTRACT
The
functions
of
the
heart
and
brain
are
closely
linked
essential
to
support
human
life
by
heart‐brain
axis,
which
is
a
complex
interconnection
between
brain.
Also,
cardiac
function
cerebral
blood
flow
regulate
brain's
metabolism
function.
Therefore,
deterioration
may
affect
cognitive
increase
risk
dementia.
Cardiogenic
dementia
defined
as
due
diseases
such
failure,
myocardial
infarction,
atrial
fibrillation.
prevalence
impairment
in
patients
with
failure
was
29%.
In
addition,
coronary
artery
disease
(CAD)
also
associated
development
impairment.
CAD
reduction
contractility
reduced
increased
patients.
Furthermore,
infarction
subsequent
systemic
haemodynamic
instability
promote
progression
cardiogenic
These
findings
indicated
that
many
implicated
Nevertheless,
underlying
mechanism
for
not
fully
elucidated.
Consequently,
this
review
aims
discuss
potential
mechanisms
involved
pathogenesis
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(1), P. 110 - 110
Published: Jan. 19, 2025
Reactive
oxygen
and
nitrogen
species
(ROS;
RNS)
are
natural
bioproducts
of
cellular
metabolism,
particularly
produced
within
the
mitochondria
during
energy
production
[...]